Company page

Adma Biologics Inc

Adma Biologics Inc, trading under the ticker ADMA, is a public company based in America with a market capitalization of approximately $1.92 billion. The company focuses on developing and manufacturing specialty biologics for the treatment of infectious diseases. Adma Biologics aims to address unmet medical needs through its innovative products and therapies.

ADMA:NASDAQUpdated August 28, 2026
Adma Biologics Inc logo
Ticker
ADMA:NASDAQ
Asset type
Stock
Market cap
$2.09B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD